140 related articles for article (PubMed ID: 34911380)
21. Complications of indwelling venous access devices in patients with gynecologic malignancies.
Estes JM; Rocconi R; Straughn JM; Bhoola S; Leath CA; Alvarez RD; Kilgore LC; Huh WK
Gynecol Oncol; 2003 Dec; 91(3):591-5. PubMed ID: 14675682
[TBL] [Abstract][Full Text] [Related]
22. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study.
Kuriakose P; Colon-Otero G; Paz-Fumagalli R
J Vasc Interv Radiol; 2002 Feb; 13(2 Pt 1):179-84. PubMed ID: 11830624
[TBL] [Abstract][Full Text] [Related]
23. Utilization and Complications of Central Venous Access Devices in Oncology Patients.
Akhtar N; Lee L
Curr Oncol; 2021 Jan; 28(1):367-377. PubMed ID: 33435136
[TBL] [Abstract][Full Text] [Related]
24. Case report: the malfunctioning implanted venous access device.
Schummer W; Schummer C; Schelenz C
Br J Nurs; 2003 Feb 27-Mar 12; 12(4):210, 212-4. PubMed ID: 12671566
[TBL] [Abstract][Full Text] [Related]
25. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
26. Comparison of complications between peripheral arm ports and central chest ports: A meta-analysis.
Wu S; Li W; Zhang Q; Li S; Wang L
J Adv Nurs; 2018 Nov; 74(11):2484-2496. PubMed ID: 29917252
[TBL] [Abstract][Full Text] [Related]
27. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities.
Greene MT; Flanders SA; Woller SC; Bernstein SJ; Chopra V
Am J Med; 2015 Sep; 128(9):986-93.e1. PubMed ID: 25940453
[TBL] [Abstract][Full Text] [Related]
28. Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases.
Schenck M; Schneider T; Rübben H; Eisenhardt A
World J Urol; 2012 Jun; 30(3):399-404. PubMed ID: 21874511
[TBL] [Abstract][Full Text] [Related]
29. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
[TBL] [Abstract][Full Text] [Related]
30. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
31. Systematic review: malfunction of totally implantable venous access devices in cancer patients.
Goossens GA; Stas M; Jérôme M; Moons P
Support Care Cancer; 2011 Jul; 19(7):883-98. PubMed ID: 21556721
[TBL] [Abstract][Full Text] [Related]
32. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
33. Comparison between Arm Port and Chest Port for Optimal Vascular Access Port in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.
Liu Y; Li LL; Xu L; Feng DD; Cao Y; Mao XY; Zheng J; Jin F; Chen B
Biomed Res Int; 2020; 2020():9082924. PubMed ID: 32104708
[TBL] [Abstract][Full Text] [Related]
34. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
Choksi A; Finnegan K; Etezadi V
Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
[TBL] [Abstract][Full Text] [Related]
35. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications.
Abdul-Rauf A; Gauderer M; Chiarucci K; Berman B
J Pediatr Hematol Oncol; 1995 Nov; 17(4):342-5. PubMed ID: 7583391
[TBL] [Abstract][Full Text] [Related]
36. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
[TBL] [Abstract][Full Text] [Related]
37. Long-term Outcome of Peripherally Implanted Venous Access Ports in the Forearm in Female Cancer Patients.
Klösges L; Meyer C; Boschewitz J; Andersson M; Rudlowski C; Schild HH; Wilhelm K
Cardiovasc Intervent Radiol; 2015 Jun; 38(3):657-64. PubMed ID: 25209595
[TBL] [Abstract][Full Text] [Related]
38. Complications of central venous access devices in paediatric haemophilia patients.
Domm JA; Hudson MG; Janco RL
Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
[TBL] [Abstract][Full Text] [Related]
39. [Complications with totally implantable venous access device. A retrospective of 116 cases].
Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
[TBL] [Abstract][Full Text] [Related]
40. Outcome of 350 implanted chest ports placed by interventional radiologists.
Shetty PC; Mody MK; Kastan DJ; Sharma RP; Burke MW; Venugopal C; Burke TH
J Vasc Interv Radiol; 1997; 8(6):991-5. PubMed ID: 9399468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
